Valion Bio, Inc.
VBIO
Rank in Stocks
#32801
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Share Price
$0.54165
Last synced: 2026-11-09
Market Cap
$1.17M
Change (1 day)
6.23%
Change (1 year)
-76.14%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Valion Bio, Inc. (VBIO)
Category
Healthcare
EPS for Valion Bio, Inc. (VBIO)
EPS as of June 2026 TTM: $-111.97
According to Valion Bio, Inc.'s latest financial reports, its current EPS (TTM) is $-111.97. At the end of 2025 the company had an EPS of $-7.84, an increase over its 2024 EPS of $-19.68.
EPS history for Valion Bio, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-111.97 | 1,328.19% |
| 2025 | $-7.84 | -60.16% |
| 2024 | $-19.68 | -88.87% |
| 2023 | $-176.80 | -90.00% |
| 2022 | $-1.77K | -57.23% |
| 2021 | $-4.13K | 519.09% |
| 2020 | $-667.69 | -12.27% |
| 2019 | $-761.09 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -113.99% |
US
|
|
| $-7.07 | -93.69% |
US
|
|
| $-5.29 | -95.28% |
AU
|
|
| $12.88 | -111.50% |
BE
|
|
| $21.56 | -119.26% |
NL
|
Questions about Valion Bio, Inc.'s earnings per share (EPS)
What is Valion Bio, Inc.'s earnings per share (EPS)?
Valion Bio, Inc.'s earnings per share (EPS) over the last twelve months is $-111.97, as of Jun 2026.
What was Valion Bio, Inc.'s earnings per share (EPS) in 2025?
In 2025, Valion Bio, Inc.'s earnings per share (EPS) was $-7.84, compared with $-19.68 in 2024.
How has Valion Bio, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Valion Bio, Inc.'s earnings per share (EPS) was highest in 2025 ($-7.84) and lowest in 2021 ($-4.13K).
How does Valion Bio, Inc.'s earnings per share (EPS) compare with similar companies?
Valion Bio, Inc.'s earnings per share (EPS) ($-111.97) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.